Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocept Inc
(NQ:
BIOC
)
0.4349
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biocept Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
March 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
6 F-Rated Penny Stocks Not Worth Your Dime
January 31, 2023
Very risky, with questionable upside potential, don't waste even a nickel on these seven penny stocks to sell.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 24, 2023
We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
Recap: Biocept Q4 Earnings
April 06, 2022
Biocept (NASDAQ:BIOC) reported its Q4 earnings results on Wednesday, April 6, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
The Jobs Report Tells A False Narrative
January 19, 2023
Today's jobless claims figure was surprisingly strong despite massive layoffs. We tell the real story here.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
OnFriday, 143 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 19, 2022
Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Gainers
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
June 27, 2022
During Monday's session, 77 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 08, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 07, 2022
Gainers
Via
Benzinga
Biocept's Return On Capital Employed Overview
May 24, 2022
According to Benzinga Pro data, during Q1, Biocept (NASDAQ:BIOC) posted sales of $19.95 million. Earnings were up 6.84%, but Biocept still reported an overall loss of $2.77 million.
Via
Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
May 22, 2022
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.
Via
Benzinga
Looking Into Biocept's Return On Capital Employed
April 07, 2022
Benzinga Pro data, Biocept (NASDAQ:BIOC) reported Q4 sales of $13.98 million. Earnings fell to a loss of $2.97 million, resulting in a 375.6% decrease from last quarter.
Via
Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via
Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
Via
Benzinga
Earnings Outlook For Biocept
March 30, 2022
Biocept (NASDAQ:BIOC) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Biocept will report...
Via
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 22, 2022
Gainers Revelation Biosciences (NASDAQ:REVB
Via
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...
Via
Benzinga
Exposures
Product Safety
Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients
September 29, 2021
Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.